Detalles de la búsqueda
1.
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥â¯60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023.
Euro Surveill
; 29(3)2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240061
2.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Euro Surveill
; 29(13)2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38551095
3.
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
Euro Surveill
; 29(8)2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38390651
4.
Effectiveness of a Second Dose of an mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in Individuals Previously Infected by Other Variants.
Clin Infect Dis
; 76(3): e367-e374, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35687580
5.
Influenza hospitalisations in Spain between the last influenza and COVID-19 pandemic (2009-2019).
Epidemiol Infect
; 151: e177, 2023 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37791484
6.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveill
; 28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997666
7.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Euro Surveill
; 28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997665
8.
Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned.
Euro Surveill
; 27(26)2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35775429
9.
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Euro Surveill
; 27(21)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35620997
10.
[Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination]. / Gravedad comparativa de los casos de COVID-19 causados por las variantes Alfa, Delta u Ómicron de SARS-CoV-2 y su asociación con la vacunación.
Enferm Infecc Microbiol Clin
; 2022 Dec 06.
Artículo
en Español
| MEDLINE | ID: mdl-36506460
11.
Real time surveillance of COVID-19 space and time clusters during the summer 2020 in Spain.
BMC Public Health
; 21(1): 961, 2021 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34016076
12.
Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021.
Euro Surveill
; 26(24)2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34142647
13.
Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021.
Euro Surveill
; 26(47)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34823641
14.
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
Euro Surveill
; 26(29)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34296676
15.
Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease.
Emerg Infect Dis
; 26(8): 1846-1851, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32687028
16.
Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020.
Euro Surveill
; 25(10)2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32183932
17.
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019.
Euro Surveill
; 24(8)2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30808440
18.
Impact of influenza vaccination programmes among the elderly population on primary care, Portugal, Spain and the Netherlands: 2015/16 to 2017/18 influenza seasons.
Euro Surveill
; 24(45)2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31718740
19.
Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination.
Enferm Infecc Microbiol Clin (Engl Ed)
; 42(4): 187-194, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36737369
20.
Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
Vaccine
; 42(16): 3547-3554, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704257